美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
17772-121-01	17772-121	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20130117	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	150 mg/1	100 TABLET in 1 BOTTLE (17772-121-01)
17772-121-07	17772-121	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20230701	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	150 mg/1	7 TABLET in 1 BOTTLE (17772-121-07)
17772-121-10	17772-121	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20130117	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	150 mg/1	5 TABLET in 1 BLISTER PACK (17772-121-10)
17772-122-01	17772-122	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20130117	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	300 mg/1	100 TABLET in 1 BOTTLE (17772-122-01)
17772-122-07	17772-122	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20230701	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	300 mg/1	7 TABLET in 1 BOTTLE (17772-122-07)
17772-122-10	17772-122	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20130117	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	300 mg/1	5 TABLET in 1 BLISTER PACK (17772-122-10)
17772-123-01	17772-123	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20130117	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	600 mg/1	100 TABLET in 1 BOTTLE (17772-123-01)
17772-123-07	17772-123	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20230701	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	600 mg/1	7 TABLET in 1 BOTTLE (17772-123-07)
17772-123-10	17772-123	HUMAN PRESCRIPTION DRUG	OXTELLAR XR	OXCARBAZEPINE	TABLET	ORAL	20130117	N/A	NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	600 mg/1	5 TABLET in 1 BLISTER PACK (17772-123-10)